4.6 Article

Escherichia coli Expressing EAST1 Toxin Did Not Cause an Increase of cAMP or cGMP Levels in Cells, and No Diarrhea in 5-Day Old Gnotobiotic Pigs

Journal

PLOS ONE
Volume 7, Issue 8, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0043203

Keywords

-

Funding

  1. National Institutes of Health [AI076871-01]
  2. South Dakota Agricultural Experiment Station

Ask authors/readers for more resources

Background: Enterotoxigenic Escherichia coli (ETEC) strains are the leading bacterial cause of diarrhea to humans and farm animals. These ETEC strains produce heat-labile toxin (LT) and/or heat-stable toxins that include type I (STa), type II (STb), and enteroaggregative heat-stable toxin 1 (EAST1). LT, STa, and STb (in pigs) are proven the virulence determinants in ETEC diarrhea. However, significance of EAST1 in ETEC-associated diarrheal has not been determined, even though EAST1 is highly prevalent among ETEC strains. Methodology/Principal Findings: In this study, we constructed E. coli strains to express EAST1 toxin as the only toxin and studied them in cell lines and five-day old gnotobiotic piglets to determine significance of EAST1 toxin. Data from in vitro studies indicated that EAST1 did not stimulate an increase of intracellular cyclic AMP or GMP levels in T-84 cells or porcine cell line IPEC-J2, nor did it enhance LT or STa toxin of ETEC strains in stimulation of cAMP or cGMP in T-84 cells. In addition, 5-day old gnotobiotic pigs challenged with E. coli strains expressing EAST1 as the only toxin did not developed diarrhea or signs of clinical disease during 72 h post-inoculation. Conclusion/Significance: Results from this study indicated that EAST1 alone is not sufficient to cause diarrhea in five-day old gnotobiotic pigs, and suggest that EAST1 likely is not a virulence determinant in ETEC-associated diarrhea.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Infectious Diseases

Development of effective vaccines for enterotoxigenic Escherichia coli

Hyesuk Seo, Weiping Zhang

LANCET INFECTIOUS DISEASES (2020)

Article Biotechnology & Applied Microbiology

Coimmunization with Two Enterotoxigenic Escherichia coli (ETEC) Fimbrial Multiepitope Fusion Antigens Induces the Production of Neutralizing Antibodies against Five ETEC Fimbriae (F4, F5, F6, F18, and F41)

Qiangde Duan, Wenwen Wu, Shengmei Pang, Zhiming Pan, Weiping Zhang, Guoqiang Zhu

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2020)

Review Gastroenterology & Hepatology

Vaccines against gastroenteritis, current progress and challenges

Hyesuk Seo, Qiangde Duan, Weiping Zhang

GUT MICROBES (2020)

Article Biotechnology & Applied Microbiology

The Intriguing Interaction of Escherichia coli with the Host Environment and Innovative Strategies To Interfere with Colonization: a Summary of the 2019 E. coli and the Mucosal Immune System Meeting

Eric Cox, Meryem Aloulou, James M. Fleckenstein, Christina Schaeffer, Asa Sjoling, Stephanie Schuller, Kurt Hanevik, Bert Devriendt, Weiping Zhang, Ann-Mari Svennerholm, Edward G. Dudley

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2020)

Article Immunology

Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate

Hyesuk Seo, Carolina Garcia, Xiaosai Ruan, Qiangde Duan, David A. Sack, Weiping Zhang

Summary: The lack of licensed vaccines for enterotoxigenic Escherichia coli (ETEC) poses a significant challenge, however, researchers have developed a novel epitope-based multiepitope fusion antigen (MEFA) vaccinology platform to construct two chimeric multivalent proteins that induced protective antibodies against key toxins and adhesins associated with ETEC. The resulting protein-based multivalent ETEC vaccine, MecVax, demonstrated broad immunogenicity and protection against ETEC diarrhea in preclinical models, highlighting its potential as an effective injectable vaccine for ETEC.

INFECTION AND IMMUNITY (2021)

Article Biotechnology & Applied Microbiology

Intradermally Administered Enterotoxigenic Escherichia coli Vaccine Candidate MecVax Induces Functional Serum Immunoglobulin G Antibodies against Seven Adhesins (CFA/I and CS1 through CS6) and Both Toxins (STa and LT)

Carolina Y. Garcia, Hyesuk Seo, David A. Sack, Weiping Zhang

Summary: This study demonstrates the broad immunogenicity of a multivalent ETEC subunit vaccine candidate and suggests that it can be effectively delivered via the intradermal route. The vaccine induces functional antibodies against ETEC adhesins and toxins when administered intradermally.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2022)

Article Infectious Diseases

A multi-epitope fusion antigen candidate vaccine for Enterotoxigenic Escherichia coli is protective against strain B7A colonization in a rabbit model

Richard M. Jones, Hyesuk Seo, Weiping Zhang, David A. Sack

Summary: The study developed a multi-epitope fusion antigen (MEFA) vaccine candidate and tested its protective effect against colonization of Enterotoxigenic E. coli (ETEC) using a rabbit model. The results showed that the vaccine generated antibodies against multiple colonization factors and prevented colonization of a challenge strain in the rabbit small intestine.

PLOS NEGLECTED TROPICAL DISEASES (2022)

Article Biotechnology & Applied Microbiology

Evaluation of Multivalent Enterotoxigenic Escherichia coli Vaccine Candidate MecVax Antigen Dose-Dependent Effect in a Murine Model

Hyesuk Seo, Qiangde Duan, Ipshita Upadhyay, Weiping Zhang

Summary: Enterotoxigenic Escherichia coli (ETEC) is a major cause of children's diarrhea and travelers' diarrhea, but there are currently no licensed vaccines against ETEC. Recent studies have shown that the protein-based vaccine candidate MecVax can generate functional antibodies against ETEC toxins and adhesins, providing protection in animal models. This study further confirms the broad immunogenicity of MecVax and evaluates the effect of vaccine antigen dose on antibody response and functional activities against ETEC toxins and bacterial adherence in mice, providing useful information for future human trials and the development of MecVax as an effective ETEC vaccine.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2022)

Article Biotechnology & Applied Microbiology

Characterization of Functional B-Cell Epitopes at the Amino Terminus of Shigella Invasion Plasmid Antigen B (IpaB)

Siqi Li, Xinfeng Han, Ipshita Upadhyay, Weiping Zhang

Summary: This study identified functional epitopes of IpaB protein, particularly from the N terminus, and proposed using them for the development of a cross-protective Shigella vaccine. Three identified epitopes showed potential for inducing protective antibodies against Shigella invasion, indicating their usefulness in vaccine development.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2022)

Article Microbiology

Intramuscularly Administered Enterotoxigenic Escherichia coli (ETEC) Vaccine Candidate MecVax Prevented H10407 Intestinal Colonization in an Adult Rabbit Colonization Model

Ipshita Upadhyay, Kathryn L. Lauder, Siqi Li, Galen Ptacek, Weiping Zhang

Summary: Currently, there is no licensed vaccine for enterotoxigenic Escherichia coli (ETEC), a major cause of diarrhea in developing countries and among travelers. A protein-based multivalent vaccine candidate called MecVax has been shown to induce antibodies that neutralize ETEC toxins and inhibit bacterial adherence. In this study, adult rabbits immunized with MecVax showed a significant reduction in intestinal colonization by ETEC, suggesting that MecVax may be an effective vaccine candidate against ETEC.

MICROBIOLOGY SPECTRUM (2022)

Article Immunology

Feasibility of avian antibodies as prophylaxis against enterotoxigenic escherichia coli colonization

Kyle Brumfield, Hyesuk Seo, Nnebuefe Idegwu, Chad Artman, Laura Gonyar, James Nataro, Weiping Zhang, David Sack, James Geyer, Julius Goepp

Summary: This research evaluates the feasibility of using avian immunoglobulins (IgY) to prevent diarrheal illness caused by enterotoxigenic Escherichia coli (ETEC). The results show that IgY can inhibit the adhesion of ETEC and has the potential to be a prophylactic treatment for diarrheal diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

A polyvalent multiepitope protein cross-protects against Vibrio cholerae infection in rabbit colonization and passive protection models

Ipshita Upadhyay, Siqi Li, Galen Ptacek, Hyesuk Seo, David A. Sack, Weiping Zhang

Summary: By using a multiepitope fusion antigen vaccinology platform, researchers constructed a polyvalent protein immunogen that can induce immune response and cross-protection. The immunogen was shown to generate antibodies against various virulence factors of Vibrio cholerae and provide protection against bacterial colonization and related diseases.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biotechnology & Applied Microbiology

Polyvalent Protein Adhesin MEFA-II Induces Functional Antibodies against Enterotoxigenic Escherichia coli (ETEC) Adhesins CS7, CS12, CS14, CS17, and CS21 and Heat-Stable Toxin (STa)

Ipshita Upadhyay, Shafiullah M. D. Parvej, Siqi Li, Kathryn L. Lauder, Yiyang Shen, Weiping Zhang

Summary: An effective vaccine against ETEC is lacking, which is a primary cause of children's and traveler's diarrhea and a global health threat. The key challenge in ETEC vaccine development is the expression of heterogeneous virulence determinants by ETEC bacteria. This study utilized a unique vaccinology platform to develop a polyvalent antigen that demonstrated broad immunogenicity and functions against targeted ETEC strains.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2023)

Article Veterinary Sciences

A multivalent vaccine candidate targeting enterotoxigenicEscherichia colifimbriae for broadly protecting against porcine post-weaning diarrhea

Qiangde Duan, Shengmei Pang, Wenwen Wu, Boyu Jiang, Weiping Zhang, Siguo Liu, Xiaojun Wang, Zhiming Pan, Guoqiang Zhu

VETERINARY RESEARCH (2020)

No Data Available